Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922788
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-04
First Post:
2021-06-08
Brief Title:
Study to Evaluate the Safety Immunogenicity and Efficacy of Nanocovax Vaccine Against COVID-19
Sponsor:
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company